“Next-Generation Cord Blood Expansion: Bridging the Cell Dose Gap with Bioengineered Niches and Clinical Breakthroughs”

Key Points

• Enhanced cell dose improves transplantation outcomes, addressing a critical gap in current therapies.
• Bioengineered niches are essential for effective and sustainable growth of stem cells in cord blood.
• Observational analysis across multiple models shows a significant increase in stem cell yield through bioengineering techniques.
• Potential improvements in cell therapies could reduce reliance on donor availability and improve patient prognosis.